Risk Arbitrage: Abbott Labs and Alza (A)

Case Solution

George Chacko, Randolph B. Cohen, Andrew Kuhlman, Marc Chennault
Harvard Business School ()

A hedge fund is trying to decide whether to take advantage of an apparent risk arbitrage opportunity that exists during Abbott Labs’ acquisition of ALZA.

We don‘t have the case solution, but we pay up to $50 for yours!

  • Set a reminder to receive an email after your university‘s case study deadline.
  • Upload your case study solution. We will review it for quality.
  • Get your money via PayPal or to your bank account.